CD154 blockade abrogates allospecific responses and enhances CD4 + regulatory T-cells in mouse orthotopic lung transplant

American Journal of Transplantation

Volumn 11, Issue 9, 2011, Pages 1815-1824

  Dodd O, J M ^a   Lendermon, E A ^a   Miller, H L ^a   Zhong, Q ^a   John, E R ^a   Jungraithmayr, W M ^b   D'Alessio, F R ^a   McDyer, J F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Allograft rejection; CD154; effector T cell; mouse orthotopic lung transplantation; regulatory T cell

Indexed keywords

CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; GRAFT RECIPIENT; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; CD4-CD8 RATIO; CD40 LIGAND; CULTURE MEDIA; FLOW CYTOMETRY; INTERFERON-GAMMA; LUNG TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

EID: 80052271489     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03623.x     Document Type: Article

References (45)

1. Christie JD, Edwards LB, Kucheryavaya AY, et al,. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant 2010; 29: 1104-1118.
2. Belperio JA, Weigt SS, Fishbein MC, Lynch JP 3rd,. Chronic lung allograft rejection: Mechanisms and therapy. Proc Am Thorac Soc 2009; 6: 108-121.
3. Wilkes DS, Egan TM, Reynolds HY,. Lung transplantation: Opportunities for research and clinical advancement. Am J Respir Crit Care Med 2005; 172: 944-955. (Pubitemid 41476530)
4. Martinu T, Howell DN, Palmer SM,. Acute cellular rejection and humoral sensitization in lung transplant recipients. Semin Respir Crit Care Med 2010; 31: 179-188.
5. Okazaki M, Krupnick AS, Kornfeld CG, et al,. A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 2007; 7: 1672-1679. (Pubitemid 46776257)
6. Elster EA, Xu H, Tadaki DK, et al,. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 2001; 72: 1473-1478. (Pubitemid 33095503)
7. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA,. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A 1996; 93: 13967-13972. (Pubitemid 26424229)
8. Markees TG, Phillips NE, Noelle RJ, et al,. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997; 64: 329-335. (Pubitemid 27332681)
9. Kirk AD, Burkly LC, Batty DS, et al,. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5: 686-693. (Pubitemid 29289433)
10. Grewal IS, Xu J, Flavell RA,. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995; 378: 617-620.
11. McDyer JF, Goletz TJ, Thomas E, June CH, Seder RA,. CD40 ligand/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J Immunol 1998; 160: 1701-1707. (Pubitemid 28106455)
12. Ensminger SM, Witzke O, Spriewald BM, et al,. CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation 2000; 69: 2609-2612. (Pubitemid 30482029)
13. Guo Z, Meng L, Kim O, et al,. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 2001; 71: 1351-1354. (Pubitemid 32507164)
14. Jones ND, Van Maurik A, Hara M, et al,. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol 2000; 165: 1111-1118. (Pubitemid 30484783)
15. Lunsford KE, Jayanshankar K, Eiring AM, et al,. Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts. Am J Transplant 2008; 8: 1113-1128. (Pubitemid 351763674)
16. Trambley J, Bingaman AW, Lin A, et al,. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715-1722. (Pubitemid 30053188)
17. Wells AD, Li XC, Li Y, et al,. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303-1307. (Pubitemid 29535609)
18. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB,. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5: 1298-1302. (Pubitemid 29535608)
19. Graca L, Honey K, Adams E, Cobbold SP, Waldmann H,. Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J Immunol 2000; 165: 4783-4786.
20. Taylor PA, Noelle RJ, Blazar BR,. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311-1318.
21. van Maurik A, Herber M, Wood KJ, Jones ND,. Cutting edge: CD4+CD25 +alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: Implications for anti-CD154 immunotherapy. J Immunol 2002; 169: 5401-5404. (Pubitemid 35291635)
22. Okazaki M, Gelman AE, Tietjens JR, et al,. Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol 2007; 37: 625-630. (Pubitemid 350211632)
23. Jungraithmayr WM, Korom S, Hillinger S, Weder W,. A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 2009; 137: 486-491.
24. Gelman AE, Okazaki M, Lai J, et al,. CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol 2008; 180: 4754-4762.
25. West EE, Lavoie TL, Orens JB, et al,. Pluripotent allospecific CD8+ effector T cells traffic to lung in murine obliterative airway disease. Am J Respir Cell Mol Biol 2006; 34: 108-118. (Pubitemid 43042863)
26. Xu S, Zhou Y, Yang S, et al,. Platelet-derived growth factor receptor alpha gene mutations in vitiligo vulgaris. Acta Derm Venereol 2010; 90: 131-135.
27. Burlingham WJ, Love RB, Jankowska-Gan E, et al,. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 3498-3506. (Pubitemid 350097005)
28. Yoshida S, Haque A, Mizobuchi T, et al,. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006; 6: 724-735. (Pubitemid 43345010)
29. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, et al,. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004; 10: 927-934. (Pubitemid 39273733)
30. Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, et al,. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 2006; 25: 643-654. (Pubitemid 44529043)
31. GeurtsvanKessel CH, Willart MA, Bergen IM, et al,. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 2009; 206: 2339-2349.
32. Gelman AE, Li W, Richardson SB, et al,. Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol 2009; 182: 3969-3973.
33. Shah PD, West EE, Whitlock AB, Orens JB, McDyer JF,. CD154 deficiency uncouples allograft CD8+ T-cell effector function from proliferation and inhibits murine airway obliteration. Am J Transplant 2009; 9: 2697-2706.
34. Fehr T, Takeuchi Y, Kurtz J, Wekerle T, Sykes M,. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8 +T cells, precluding a role for sustained regulation. Eur J Immunol 2005; 35: 2679-2690. (Pubitemid 41404051)
35. Zhai Y, Shen XD, Gao F, et al,. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation. J Immunol 2002; 169: 1270-1276. (Pubitemid 34809168)
36. Wu Z, Wang Y, Gao F, Shen X, Zhai Y, Kupiec-Weglinski JW,. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients. J Immunol 2008; 181: 1096-1102.
37. Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL,. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512-521. (Pubitemid 30013028)
38. Haspot F, Fehr T, Gibbons C, et al,. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Blood 2008; 112: 2149-2155.
39. Okazaki M, Sugimoto S, Lai J, et al,. Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient. Transplant Proc 2009; 41: 385-387.
40. Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW,. Recruitment of Foxp3 +T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201: 1037-1044. (Pubitemid 40524671)
41. Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR,. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002; 99: 4601-4609. (Pubitemid 34627233)
42. Walsh PT, Taylor DK, Turka LA,. Tregs and transplantation tolerance. J Clin Invest 2004; 114: 1398-1403. (Pubitemid 40385567)
43. Verbinnen B, Billiau AD, Vermeiren J, et al,. Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade. J Immunol 2008; 181: 1034-1042.
44. Meng L, Wu Z, Wang Y, et al,. Differential impact of CD154 costimulation blockade on alloreactive effector and regulatory T cells in murine renal transplant recipients. Transplantation 2008; 85: 1332-1338. (Pubitemid 351670485)
45. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB,. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000; 6: 114. (Pubitemid 30082329)